Isatuximab Quadruplet Approval Could Change the Landscape for Treating MyelomaOctober 7, 2024Multiple MyelomaTransplantation
Personalized cancer vaccine shows early promise across tumor typesApril 14, 2021Multiple MyelomaLymphoma & Plasma Cell Disorders
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaMyelodysplastic SyndromeTransplantation
Maintaining cancer care in the face of COVID-19April 1, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatrics
FDA approves new drug for relapsed/refractory multiple myelomaMarch 2, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
CRISPR-engineered T cells may be safe for cancer, but do they work?February 6, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Start of myeloma therapy may be delayed for women, minoritiesJanuary 21, 2020Multiple MyelomaLymphoma & Plasma Cell Disorders
Inhibitor appears to strengthen anti-BCMA CAR T cells in myeloma patientsDecember 23, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
D-RVd for frontline myeloma looks robust in GRIFFIN trial updateDecember 17, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Myeloma patients over age 70 can benefit from auto-HC transplantDecember 7, 2019TransplantationMultiple MyelomaLymphoma & Plasma Cell Disorders
Foundation launches direct-to-patient registry in multiple myelomaNovember 13, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
SEER analysis reveals medication adherence factors in newly diagnosed myelomaOctober 24, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
What is the optimal duration of maintenance in myeloma?October 8, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Study finds no standard for treatment discontinuation in myelomaOctober 1, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Second-generation anti-BCMA CAR T-cell therapy shows promise in myeloma trialSeptember 27, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
